Home » Newsletters » BioWorld Science

BioWorld Science

July 15, 1997

View Archived Issues

New insights into glaucoma and implications for drug therapy

Rutaecarpine, a vasorelaxant component of an herbal drug

New treatment reported for diaper dermatitis

Englitazone mechanism of antidiabetic activity studied in vitro

Mechanism of topical absorption of antiandrogen drug investigated

Maxamine enters phase III for malignant melanoma

Interim U.S. phase III results reported for Gliatech's ADCON-L

ArQule and Wyeth-Ayerst enter into drug discovery collaboration

HIV protease inhibitor enters phase III pediatric trial

NeoTherapeutics begins U.S. clinical trials of AIT-082

Teva receives FDA approval for generic estazolam

The Population Council licenses two hormone replacement products to Sano

Update on CellPro's CEPRATE SC Stem Cell Concentration System

Allergan prepares compounds with retinoid-like activity

MMP inhibitors from Warner-Lambert

Celltech discloses potent and selective inhibitors of protein kinases

MS&D reveals agents for migraine

Chiroscience claims MMP/TNF inhibitors

Dual H1/NK1 antagonists from Hoechst Marion Roussel

Univ. of Pennsylvania team discovers new Alzheimer's lesion

ICRF-187 for preventing anthracycline cardiotoxicity in children

Immunomedics issued U.S. patent for cardiovascular diagnostic

Mibefradil more effective than extended-release diltiazem in hypertension

Efficacy of botulinum toxin type C in humans

Vitamin B12 depletion reported to induce apoptosis

Potent and selective M2 receptor antagonist discovered by Yamanouchi

Geron's telomerase technology covered under U.S. patent

Dainippon presents promising antisecretory agent

Bigmar submits ANDA for leucovorin

NIH researchers identify gene associated with Niemann-Pick type C

Eclipse submits PMA for Transmyocardial Revascularization procedure

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 17, 2025.
Zusduri flurry ends; ‘set up’ at ODAC, Urogen prevails with FDA
BioWorld
During a conference call after the U.S. FDA approval of Zusduri (mitomycin), Urogen Pharma Ltd. CEO Liz Barrett offered candid observations about a...
23andme founder-led group outbids Regeneron for company
BioWorld
The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...
Elevidys’ second liver death hits Sarepta, sends DMD ripples
BioWorld
How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...